HRQOL of Life After ECMO Due to COVID-19.
NCT05531032 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 44
Last updated 2025-04-13
Summary
We intend to prospectively investigate physical and mental state (HRQOL) by means of quantitative telephone interviews after hospital discharge in patients surviving COVID-19 ARDS and ECMO therapy.
Conditions
- ARDS
- COVID-19 Pneumonia
- Extracorporeal Membrane Oxygenation
Interventions
- OTHER
-
Phone Interview
Phone interview questionnaire
Sponsors & Collaborators
-
Medical University of Vienna
lead OTHER
Principal Investigators
-
Alexander Hermann, Dr. · MUW
Study Design
- Allocation
- NA
- Purpose
- HEALTH_SERVICES_RESEARCH
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-08-30
- Primary Completion
- 2024-10-31
- Completion
- 2024-10-31
Countries
- Austria
Study Locations
More Related Trials
-
PRactice of VENTilation in Patients With ARDS Due to COVID-19 vs Pneumonia
NCT05650957 ·Status: COMPLETED
-
Place of ECMO in the Management of Severe Refractory ARDS Associated With Covid-19
NCT04343404 ·Status: COMPLETED
-
Extracorporeal Membrane Oxygenation for Severe Acute Respiratory Distress Syndrome
NCT01470703 ·Status: COMPLETED ·Phase: NA
-
The Effect of Lt to Rt Shunt Using Veno-veno-arterial Extracorporeal Membrane Oxygenation (ECMO) on Coronary Oxygenation in Lung Transplantation Patients
NCT02859194 ·Status: COMPLETED ·Phase: NA
-
Australia and New Zealand Adult Extracorporeal Membrane Oxygenation (ECMO) Audit 2005
NCT00157144 ·Status: COMPLETED
-
Trial of Venovenous ECMO to De-Sedate, Extubate and Mobilise in Hypoxic Respiratory Failure
NCT05562505 ·Status: RECRUITING ·Phase: NA
-
Extracorporeal Support for Respiratory Insufficiency (ECMO)
NCT00000562 ·Status: COMPLETED ·Phase: PHASE3
-
Ultraprotective Ventilation Without Extracorporeal Circulation During COVID 19 Pneumonia
NCT04349618 ·Status: COMPLETED ·Phase: NA
-
Respiratory and Hemodynamic Changes Induced in Mechanically Ventilated Patients for COVID-19
NCT04347928 ·Status: COMPLETED
-
Safety and Efficacy of Low-Flow ECMO in a Multi-modal Cohort of Adults in Respiratory Failure
NCT06938217 ·Status: ENROLLING_BY_INVITATION ·Phase: NA
-
Impact of Non-invasive Positive Pressure Ventilation on Cardiac Function and Echocardiographic Parameters
NCT02267291 ·Status: COMPLETED ·Phase: NA
-
Ventilator Strategies in ICU Patients With COVID-19 - a National-wide Retrospective Observational Study.
NCT05102630 ·Status: UNKNOWN
-
Observational Cohort Study of a National Extracorporeal Membrane Oxygenation Service for Adults With Respiratory Failure: the NHS ECMO Study.
NCT03979222 ·Status: COMPLETED
-
Closed Loop Mechanical Ventilation and ECMO
NCT04925518 ·Status: COMPLETED ·Phase: NA
-
Measuring Energy Expenditure in ECMO (Extracorporeal Membrane Oxygenation) Patients
NCT01992237 ·Status: UNKNOWN
-
Assessment of Lung Mechanics in COVID-19 Acute Respiratory Distress Syndrome
NCT04597853 ·Status: UNKNOWN
-
Flow-controlled Ventilation (FCV) in Moderate Acute Respiratory Distress Syndrome (ARDS) Due to COVID-19
NCT04894214 ·Status: COMPLETED
-
ECMO for Critically Ill Patients With Respiratory Failure and/or Circulatory Failure
NCT04031794 ·Status: UNKNOWN
-
Altered Respiratory Compliance Under Invasive Mechanical Ventilation in SARS-CoV-2 & Development of Respiratory Sequels
NCT05721768 ·Status: UNKNOWN
-
Short-term Physical Function Outcomes in Severe COVID-19 Patients Admitted to ICU for Invasive Mechanical Ventilation
NCT04400461 ·Status: COMPLETED
-
Enhanced Lung Protective Ventilation With ECCO2R During ARDS
NCT03525691 ·Status: TERMINATED ·Phase: NA
-
Early-initiated High Flow Oxygen Therapy vs Conventional Oxygen Therapy Among Patients With ARDS in the Course of SARS-CoV2 Pneumonia.
NCT05197686 ·Status: UNKNOWN ·Phase: NA
-
Strategies for Optimal Lung Ventilation in ECMO for ARDS: The SOLVE ARDS Study
NCT01990456 ·Status: UNKNOWN ·Phase: NA
-
Ventilatory Efficiency in Critically Ill COVID-19 Patients
NCT04694742 ·Status: UNKNOWN
-
We Compared the Covid-19 Acute Respiratory Distress Syndrome (ARDS) Patients Who Applied Prone Positioning for16-24 Hours vs 24-48 Hours
NCT06530095 ·Status: COMPLETED